Beauty Comparison

Medications That Cause Hair Loss in Women: Full List

Reviewed June 2026 6 min read 6 sources

The short answer

Over 300 medications can trigger hair loss in women.

Why Medications Cause Hair Loss

Hair loss triggered by a drug is called drug-induced alopecia. It is far more common than most patients and clinicians expect — more than 300 prescription and over-the-counter medications have been implicated. In women, who are already at greater risk of hormonally driven hair loss, a drug trigger can compound an underlying predisposition.

Two distinct mechanisms account for almost all cases:

Telogen Effluvium (the most common mechanism)

The drug prematurely pushes growing (anagen) follicles into the resting (telogen) phase. After approximately 2–3 months — the normal duration of telogen — those follicles shed simultaneously, causing a diffuse increase in daily shedding rather than a bald patch. The hair is lost in its normal telogen (club) form with a white bulb at the root. Because of this delay, patients often cannot connect the hair loss to the medication that started it.

Anagen Effluvium (predominantly chemotherapy)

The drug directly damages the rapidly dividing matrix cells of actively growing follicles, causing the hair shaft to taper, fracture, and break at the scalp surface. Onset is rapid — often within 2–5 weeks of exposure. Loss can be extensive and distressing but is nearly always reversible once treatment ends.


The Full Category-by-Category List

Anticoagulants (Blood Thinners)

All anticoagulant classes have been implicated in telogen effluvium, though the exact risk rate is poorly quantified because anticoagulant patients are often acutely unwell:

Drug Notes
Heparin (unfractionated and low-molecular-weight) Among the most frequently reported; dose-dependent
Warfarin Reported consistently across decades
Rivaroxaban (Xarelto) Listed in prescribing information; risk appears similar to warfarin
Dabigatran (Pradaxa) Reported in pharmacovigilance data
Apixaban (Eliquis) Reported; likely class effect

Onset: Typically 2–4 months after starting or increasing the dose.


Antihypertensives

Beta-blockers and ACE inhibitors are the most frequently reported antihypertensive causes:

Drug Class
Propranolol, metoprolol, atenolol Beta-blockers
Captopril, enalapril, lisinopril ACE inhibitors

Beta-blocker-induced hair loss may also have a direct follicular effect beyond simple telogen shift. Calcium channel blockers (amlodipine, diltiazem) are occasionally reported but less commonly.


Hormonal Agents

This is particularly relevant to women. Hormonal therapies can cause hair loss during use, on initiation, or paradoxically on discontinuation:

Drug/Class Mechanism Timing
Combined oral contraceptive pills (stopping) Withdrawal of estrogen prolong anagen → telogen shift 1–3 months after stopping
Progesterone-dominant pills / implants Androgenic progestins trigger androgenetic pattern loss in susceptible women During use
Levonorgestrel, norethindrone High androgenic index; most likely to cause hair thinning During use
Androgens / anabolic steroids Direct androgen excess at the follicle During use
Danazol Androgenic; used in endometriosis During use
HRT (hormone replacement therapy) Less commonly implicated; see context for type and dose Variable

When evaluating pill-related hair loss, the androgenicity of the progestin component matters: desogestrel, norgestimate, and drospirenone have the lowest androgenic profiles, while levonorgestrel and norethindrone are the highest.


Anticonvulsants

Valproic acid (sodium valproate / Depakote) has the highest documented incidence of hair loss of any anticonvulsant — affecting 12–28% of users — and can cause both diffuse telogen effluvium and changes in hair texture (hair becomes wavier or curlier). The mechanism is thought to include effects on zinc metabolism and biotin cycling:

Drug Estimated hair loss rate
Valproic acid 12–28%
Carbamazepine (Tegretol) ~6%
Phenytoin (Dilantin) Occasional reports
Lamotrigine Less frequently reported

Mood Stabilizers and Psychiatric Medications

Lithium causes telogen effluvium in 12–19% of users, making it one of the most common drug causes of hair loss overall. Most antidepressants and antipsychotics carry lower but non-zero risk:

Drug Class Examples
Mood stabilizers Lithium
Antidepressants (SSRIs) Fluoxetine, sertraline, paroxetine — individual reports; low overall incidence
Antidepressants (others) Bupropion, venlafaxine — case reports
Antipsychotics Variable; clozapine and olanzapine occasionally reported
Anti-anxiety Some benzodiazepines — rare case reports

Retinoids

Both oral and topical retinoids can cause hair loss, though oral isotretinoin (Accutane) used for acne is the most clinically significant. Oral retinoids accelerate telogen conversion, typically causing diffuse shedding 1–3 months into treatment. Topical retinoids (tretinoin) cause hair loss much less commonly.


Antifungal Agents

Voriconazole (a systemic antifungal used for serious infections) is particularly documented; fluconazole has occasional case reports. Terbinafine (Lamisil), used for onychomycosis, carries a low risk.


Cholesterol-Lowering Agents (Statins)

Statins are a widely discussed but actually low-incidence cause of hair loss. Post-marketing reports exist for atorvastatin and simvastatin, but the absolute risk is low, and causation is complicated by confounding (older age, underlying illness). If noticed, shedding is typically mild and often resolves without discontinuation.


Chemotherapy Agents

Cytotoxic chemotherapy causes anagen effluvium — the most severe and rapid drug-induced hair loss. Nearly all hair may be lost within weeks of starting treatment. The good news: regrowth almost always begins within 3–6 months of completing treatment. Some patients notice a temporary change in hair texture or color after regrowth.

Drugs with the highest rates of complete alopecia include:

  • Cyclophosphamide, doxorubicin, etoposide, paclitaxel, docetaxel

Scalp cooling (cooling caps) worn during infusion reduces blood flow to follicles, limiting drug exposure and reducing hair loss in selected chemotherapy regimens; discuss this option with your oncologist.


Immunosuppressants and Biologic Agents

Newer biologic agents — including immune checkpoint inhibitors (nivolumab, pembrolizumab) and anti-CD20 therapies (rituximab) — can trigger inflammatory hair disorders with increased catagen/telogen follicles. Methotrexate and azathioprine can also cause hair loss; the latter through direct follicular toxicity.


Other Medications to Know

Drug Use
Levodopa / bromocriptine Parkinson's disease
Amphetamines ADHD, narcolepsy
Interferons (alpha, beta, gamma) Hepatitis C, MS
Allopurinol Gout
NSAIDs (high-dose, chronic) Pain / anti-inflammatory — rare, low-risk
Cimetidine Acid suppression
Antithyroid drugs (propylthiouracil, methimazole) Hyperthyroidism

Identifying Drug-Induced Hair Loss: The Key Steps

  1. Timeline: Hair loss appearing approximately 2–4 months after starting, increasing the dose of, or switching a medication is the strongest clue.
  2. Pattern: Diffuse shedding across the scalp (not a defined bald patch) points toward telogen effluvium.
  3. Drug history: List every medication — prescription, OTC, hormonal, herbal, or supplement — started in the three months before shedding began.
  4. Rule out other causes: Iron deficiency, thyroid disease, and nutritional deficiencies can mimic drug-induced telogen effluvium and are often checked simultaneously with a blood panel (CBC, ferritin, TSH, vitamin D).

Will My Hair Grow Back?

In the vast majority of drug-induced cases, yes — hair loss reverses once the offending medication is stopped:

  • Shedding reduces: 3–6 months after discontinuation
  • Visible regrowth: 3–6 months after shedding stops
  • Cosmetically significant recovery: 12–18 months

The exception is long-term androgenetic alopecia triggered or unmasked by androgenic medications in genetically susceptible women — this may persist and require specific treatment even after stopping the drug.


What to Do: Never Stop a Medication Without Medical Advice

The most important practical point: do not stop a prescribed medication because you suspect it is causing hair loss without first speaking to the prescribing doctor or a dermatologist. For most conditions — epilepsy, anticoagulation after a clot, lithium for bipolar disorder — the risks of abrupt discontinuation are serious, and options including dose adjustment or switching to an alternative drug with a lower hair-loss profile almost always exist.

If you believe a medication is causing hair loss, see a dermatologist to confirm the diagnosis, then work with your prescriber to review your options. The hair loss dermatologist visit guide covers exactly what to expect from that appointment.

Products that fit: thinning hair

Picked by code from each product's full ingredient list.

Affiliate

Amazon UK prices as of 6 November 2026, 06:19 GMT; Amazon sets the final price at checkout.

See the full guide: Best Shampoos for Thinning Hair →

Frequently asked questions

What medications are most likely to cause hair loss in women?

The highest-risk medications for drug-induced hair loss in women are valproic acid (12–28% incidence), lithium (12–19%), heparin, beta-blockers such as propranolol and metoprolol, ACE inhibitors, oral contraceptives with high-androgenicity progestins (levonorgestrel, norethindrone), and isotretinoin (oral retinoid). Chemotherapy drugs cause the most severe and rapid hair loss through a different mechanism (anagen effluvium rather than telogen effluvium).

How long after starting a medication does drug-induced hair loss appear?

Most drug-induced telogen effluvium appears 2–4 months after starting, increasing the dose of, or switching the offending medication. This lag corresponds to the normal telogen phase duration — follicles pushed prematurely into rest then shed on their usual 3-month cycle. Chemotherapy-related anagen effluvium is an exception, appearing within 2–5 weeks of starting treatment.

Will hair loss stop if I stop the medication?

In most cases, yes. Shedding typically slows and stops within 3–6 months of discontinuing the responsible drug, with visible regrowth following over the next 3–6 months. Cosmetically significant recovery usually takes 12–18 months total. The exception is if the medication unmasked underlying androgenetic alopecia in a genetically susceptible person — that component may persist and need separate treatment.

Can birth control pills cause hair loss?

Yes, in two ways. Stopping the pill triggers a temporary telogen effluvium 1–3 months after discontinuation as estrogen levels drop. Additionally, pills containing androgenic progestins (levonorgestrel, norethindrone, norgestrel) can provoke androgenetic-pattern thinning in women who are genetically susceptible. Pills with anti-androgenic or low-androgenicity progestins (drospirenone, desogestrel, norgestimate) carry a lower hair-loss risk and can even be used therapeutically for hormonally driven hair loss.

Can I take anything to reduce hair loss while staying on the medication?

Evidence for supplements that prevent drug-induced telogen effluvium is limited. Valproic acid-induced hair loss may respond to zinc supplementation (valproate may deplete zinc). Biotin supplementation is sometimes recommended but only corrects a biotin deficiency, which valproate may cause. Minoxidil (2% or 5% topical foam) can support regrowth while you remain on an unavoidable medication. Always discuss any additions with your doctor.

Do statins cause hair loss?

Statins appear in post-marketing reports as a possible cause of hair loss, but the absolute incidence is low and causation is difficult to establish given that older age and cardiovascular disease independently increase hair loss risk. If you notice hair thinning on a statin, mention it to your doctor — alternatives within the class or a non-statin lipid-lowering approach may be considered — but do not stop a prescribed statin without medical advice.

Health information, not medical advice.

Beauty Comparison is an independent editorial publication. This page is researched and sourced to the authorities listed below, but it is general information — not a diagnosis or a substitute for personalised advice from a qualified doctor, dermatologist or pharmacist. If your symptoms are severe, spreading, painful, or not improving, see a healthcare professional.

Sources

  1. 01Alopecia from drugs — DermNet — DermNet NZ. Comprehensive categorized list of drugs causing telogen effluvium and anagen effluvium, including anticoagulants, beta-blockers, hormonal agents, anticonvulsants, lithium, retinoids, and chemotherapy; onset 2–4 months; reversible in 6–18 months.
  2. 02Culprits of Medication-Induced Telogen Effluvium, Part 1 — PubMed / Cutis, 2024-01-01. Peer-reviewed review of systemic retinoids, antifungals, and psychotropic medications as causes of medication-induced telogen effluvium; confirms reversible, nonscarring alopecia; inciting cause difficult to identify due to clinical delay.
  3. 03Culprits of Medication-Induced Telogen Effluvium, Part 2 — PubMed / Cutis, 2024-03-01. Second part of review covering endocrine therapies, monoclonal antibodies, and antidiabetic medications as causes of medication-induced telogen effluvium.
  4. 04Telogen Effluvium: A Review — PubMed Central / International Journal of Trichology. Drug triggers for telogen effluvium include oral retinoids, oral contraceptives, antithyroid drugs, anticonvulsants, beta-blockers, captopril, and amphetamines; onset 2–3 months post-trigger; shedding ceases 3–6 months after discontinuation; cosmetic recovery in 12–18 months.
  5. 05Hair Loss in Women: Causes, Treatment & Prevention — Cleveland Clinic. Medications listed as a recognized cause of hair loss in women; diagnostic workup includes hair pull test, scalp microscopy, blood work (vitamin D, B vitamins, zinc, iron, thyroid hormones), and scalp biopsy.
  6. 06Hair loss: Diagnosis and treatment — American Academy of Dermatology (aad.org). AAD guidance on diagnosing hair loss including examination of scalp and nails, blood tests for vitamin deficiency and hormone imbalance, and scalp biopsy to confirm diagnosis.